The trial was preregistered at ClinicalTrials.gov (NCT06309667) on February 14, 2024, and conducted in accordance with the Declaration of Helsinki and the International Council for Harmonisation Good Clinical Practice guidelines
Front Neurol 13:1095606 Thapaliya K, Marshall-Gradisnik S, Staines D, Barnden L (2021) Diffusion tensor imaging reveals neuronal microstructural changes in myalgic encephalomyelitis/chronic fatigue syndrome
Mitapivat is an oral, small-molecule activator of pyruvate kinase R (PKR) designed to increase red blood cell ATP production, thereby reducing the sickling of hemoglobin S-containing erythrocytes
GENETIC MATCHING HYPOTHESES, BRP Endogenous peptides have endogenous regulation, which is what makes the genetic-architecture conversation different here than for the engineered molecules
In the European Union, the equivalent is a Clinical Trial Application (CTA)
However, the effect of D-allulose on body weight was modest, with a decrease in BMI by 038 kg/m 2 in the high-dose v